150 related articles for article (PubMed ID: 38444706)
1. Cerasome Versus Liposome: A Comparative Pharmacokinetic Analysis Following Intravenous Administration into Rats.
Bahri S; Abdollahizad E; Mahlooji I; Rezaee E; Abbasian Z; Dadashzadeh S
Iran J Pharm Res; 2023; 22(1):e138362. PubMed ID: 38444706
[TBL] [Abstract][Full Text] [Related]
2. The effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in rats.
Dadashzadeh S; Vali AM; Rezaie M
Int J Pharm; 2008 Apr; 353(1-2):251-9. PubMed ID: 18191511
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in liposomal nanohybrid cerasomes as promising drug nanocarriers.
Yue X; Dai Z
Adv Colloid Interface Sci; 2014 May; 207():32-42. PubMed ID: 24368133
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of lipidic organoalkoxysilanes for the self-assembly of liposomal nanohybrid cerasomes with controlled drug release properties.
Liang X; Li X; Jing L; Xue P; Jiang L; Ren Q; Dai Z
Chemistry; 2013 Nov; 19(47):16113-21. PubMed ID: 24123292
[TBL] [Abstract][Full Text] [Related]
5. [Preparation of paraoxonase liposomes and their pharmacokinetics in rats].
Han Z; Jiang S; Fu B; Zhao M
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Nov; 29(11):1021-1025. PubMed ID: 29151419
[TBL] [Abstract][Full Text] [Related]
6. Lipoamino acid-based cerasomes for doxorubicin delivery: Preparation and in vitro evaluation.
Gileva A; Sarychev G; Kondrya U; Mironova M; Sapach A; Selina O; Budanova U; Burov S; Sebyakin Y; Markvicheva E
Mater Sci Eng C Mater Biol Appl; 2019 Jul; 100():724-734. PubMed ID: 30948110
[TBL] [Abstract][Full Text] [Related]
7. Comparative effects of PEG-containing liposomal formulations on in vivo pharmacokinetics of streptokinase.
Jin SE; Kim IS; Kim CK
Arch Pharm Res; 2015 Oct; 38(10):1822-9. PubMed ID: 25851624
[TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of a novel organic-inorganic nanohybrid "cerasome" formed with a liposomal membrane and silicate surface.
Katagiri K; Hashizume M; Ariga K; Terashima T; Kikuchi J
Chemistry; 2007; 13(18):5272-81. PubMed ID: 17407115
[TBL] [Abstract][Full Text] [Related]
9. Encapsulation into PEG-liposomes does not improve the bioavailability of pulmonary delivered salmon calcitonin.
Swaminathan J; Gobbo OL; Tewes F; Healy AM; Ehrhardt C
J Aerosol Med Pulm Drug Deliv; 2014 Feb; 27(1):1-11. PubMed ID: 24252061
[TBL] [Abstract][Full Text] [Related]
10. Preparation, Characterization, and In Vitro Pharmacodynamics and Pharmacokinetics Evaluation of PEGylated Urolithin A Liposomes.
Yi S; Zhang C; Hu J; Meng Y; Chen L; Yu H; Li S; Wang G; Zheng G; Qiu Z
AAPS PharmSciTech; 2021 Jan; 22(1):26. PubMed ID: 33404864
[TBL] [Abstract][Full Text] [Related]
11. Cerasomal doxorubicin with long-term storage stability and controllable sustained release.
Jin Y; Yue X; Zhang Q; Wu X; Cao Z; Dai Z
Acta Biomater; 2012 Sep; 8(9):3372-80. PubMed ID: 22659275
[TBL] [Abstract][Full Text] [Related]
12. Iron complexation to histone deacetylase inhibitors SAHA and LAQ824 in PEGylated liposomes can considerably improve pharmacokinetics in rats.
Wang Y; Tu S; Steffen D; Xiong M
J Pharm Pharm Sci; 2014; 17(4):583-602. PubMed ID: 25579435
[TBL] [Abstract][Full Text] [Related]
13. Nanohybrid liposomal cerasomes with good physiological stability and rapid temperature responsiveness for high intensity focused ultrasound triggered local chemotherapy of cancer.
Liang X; Gao J; Jiang L; Luo J; Jing L; Li X; Jin Y; Dai Z
ACS Nano; 2015 Feb; 9(2):1280-93. PubMed ID: 25599568
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies.
Gabizon A; Shmeeda H; Barenholz Y
Clin Pharmacokinet; 2003; 42(5):419-36. PubMed ID: 12739982
[TBL] [Abstract][Full Text] [Related]
15. Dose-Dependent Production of Anti-PEG IgM after Intramuscular PEGylated-Hydrogenated Soy Phosphatidylcholine Liposomes, but Not Lipid Nanoparticle Formulations of DNA, Correlates with the Plasma Clearance of PEGylated Liposomal Doxorubicin in Rats.
Subasic CN; Butcher NJ; Minchin RF; Kaminskas LM
Mol Pharm; 2023 Jul; 20(7):3494-3504. PubMed ID: 37256791
[TBL] [Abstract][Full Text] [Related]
16. The Formation of Morphologically Stable Lipid Nanocarriers for Glioma Therapy.
Pavlov R; Romanova E; Kuznetsov D; Lyubina A; Amerhanova S; Voloshina A; Buzyurova D; Babaev V; Zueva I; Petrov K; Lukashenko S; Gaynanova G; Zakharova L
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835043
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of temoporfin-loaded liposome formulations: correlation of liposome and temoporfin blood concentration.
Decker C; Schubert H; May S; Fahr A
J Control Release; 2013 Mar; 166(3):277-85. PubMed ID: 23313962
[TBL] [Abstract][Full Text] [Related]
18. Cerasomes: Soft Interface for Redox Enzyme Electrochemical Signal Transmission.
Qiao Y; Tahara K; Zhang Q; Song XM; Kikuchi J
Chemistry; 2016 Jan; 22(4):1340-8. PubMed ID: 26671064
[TBL] [Abstract][Full Text] [Related]
19. Enhanced pharmacokinetics and anti-tumor efficacy of PEGylated liposomal rhaponticin and plasma protein binding ability of rhaponticin.
Sun Y; Zhao Y
J Nanosci Nanotechnol; 2012 Oct; 12(10):7677-84. PubMed ID: 23421127
[TBL] [Abstract][Full Text] [Related]
20. Self-assembly of novel fluorescent quantum dot-cerasome hybrid for bioelectrochemistry.
Liu D; Zhuang Q; Zhang L; Zhang H; Wu S; Kikuchi J; Han Z; Zhang Q; Song XM
Talanta; 2016 Jul; 154():31-7. PubMed ID: 27154645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
